Company profile
AimVion A/S company profile
AimVion is a privately held research and development company focused on peptide based drugs for inflammatory and autoimmune diseases. The company was founded in 2015 based on its proprietary technology for a new class of anti-inflammatory peptides derived from human genetic elements. AimVion brings a team of experienced scientists, researchers and business man together to fulfill the need for better, safer and cheaper anti-inflammatory drugs of the future. The company has quickly established a portfolio of anti-inflammatory peptides in pre-clinical development stage and has focus on Rheumatoid Arthritis and Multiple Sclerosis as its primary indications.
Business identity
- Website
- https://aimvion.com/
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2015-01-01
Headquarters
- Headquarters
- Århus, Central Jutland, Denmark
- Postal code
- 8200
- Country code
- DK
- Continent
- Europe